MAPT and frontotemporal dementia: Additional support for this idea is provided by the neurodegenerative phenotype observed in mice expressing human tau protein containing the P301L mutation (Lewis et al., 2000), one of the first pathogenic MAPT mutations identified in patients with familial frontotemporal dementia (FTD) (Hutton et al., 1998).